November 2022 was a significant time for Revna Biosciences as we introduced our new facility and began our journey of providing advanced molecular diagnostics.
As we mark this milestone, we want to express our gratitude to our team, partners, and the wider community.
#RevnaBio
Revna Biosciences is excited to announce our latest strides in cancer research, addressing unmet needs in oncology care. Our collaboration with #DiatechPharmacogenetics is bringing advanced molecular diagnostic testing for cancer to West Africa.
https://t.co/2Mk3UcJm6c
@fdaghana
Dear Virginia Palmer, let me reassure you and the @USEmbassyGhana that Ghana remains welcoming and open to American investors as a stable, viable democracy. We welcome investors who value the principles of integrity and respect the cultural values of their partners. 🦁🇬🇭
Revna Biosciences is a precision medicine research company that provides advanced molecular diagnostics services. We will be participating in the @NMIMR_UG Annual Research Meeting as a gold attendee on the 17th and 18th November.
#ARM2022#Bridgingtheresearchpolicydivide#Revna
@NAkufoAddo When persuasion fails, force must be applied. I think it's time to go pass the long talks and remarks that seem not to tickle anybody. The future of our children are on the line